Cargando…

Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review

INTRODUCTION: Small-scale clinical studies with psychedelic drugs have shown promising results for the treatment of several mental disorders. Before psychedelics become registered medicines, it is important to know the full range of adverse events (AEs) for making balanced treatment decisions. OBJEC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Breeksema, Joost J, Kuin, Bouwe W, Kamphuis, Jeanine, van den Brink, Wim, Vermetten, Eric, Schoevers, Robert A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548934/ https://www.ncbi.nlm.nih.gov/pubmed/36017784 http://dx.doi.org/10.1177/02698811221116926

Ejemplares similares

Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study
por: Breeksema, Joost J., et al.
Publicado: (2023)

Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study
por: Breeksema, Joost J., et al.
Publicado: (2022)

Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies
por: Breeksema, Joost J., et al.
Publicado: (2020)

Reviewing the Potential of Psychedelics for the Treatment of PTSD
por: Krediet, Erwin, et al.
Publicado: (2020)

Serotonergic Psychedelics in Neural Plasticity
por: Lukasiewicz, Kacper, et al.
Publicado: (2021)

Working with Weirdness: A Response to “Moving Past Mysticism in Psychedelic Science”
por: Breeksema, Joost J., et al.
Publicado: (2021)

The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics
por: Evens, Ricarda, et al.
Publicado: (2023)

Serotonergic Psychedelics Temporarily Modify Information Transfer in Humans
por: Alonso, Joan Francesc, et al.
Publicado: (2015)

Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder
por: Markopoulos, Athanasios, et al.
Publicado: (2022)

Developing a new national MDMA policy: Results of a multi-decision multi-criterion decision analysis
por: van Amsterdam, Jan, et al.
Publicado: (2021)

Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics
por: Schindler, Emmanuelle A. D., et al.
Publicado: (2018)

How do serotonergic psychedelics treat depression: The potential role of neuroplasticity
por: Artin, Hewa, et al.
Publicado: (2021)

Neuropsychological Functioning in Users of Serotonergic Psychedelics – A Systematic Review and Meta-Analysis
por: Basedow, Lukas A., et al.
Publicado: (2021)

Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality
por: Jones, Grant M., et al.
Publicado: (2022)

Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents
por: Jones, Grant, et al.
Publicado: (2022)

The Nature of 3, 4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonergic Dysfunction: Evidence for and Against the Neurodegeneration Hypothesis
por: Biezonski, Dominik K, et al.
Publicado: (2011)

MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens
por: Müller, Felix, et al.
Publicado: (2020)

Serotonergic psychedelic treatment for obesity and eating disorders: potential expectations and caveats for emerging studies
por: Borgland, Stephanie L., et al.
Publicado: (2022)

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?
por: Husain, Muhammad Ishrat, et al.
Publicado: (2023)

Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions
por: Godes, Macha, et al.
Publicado: (2023)

Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer
por: dos Santos, Rafael Guimarães, et al.
Publicado: (2019)

Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems
por: Argento, Elena, et al.
Publicado: (2021)

Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample
por: Jones, Grant, et al.
Publicado: (2023)

Non-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma Cells
por: Popova, Dina, et al.
Publicado: (2016)

Hard Boiled: Alcohol Use as a Risk Factor for MDMA-Induced Hyperthermia: a Systematic Review
por: van Amsterdam, Jan, et al.
Publicado: (2021)

Concomitant medications associated with ischemic, hypertensive, and arrhythmic events in MDMA users in FDA adverse event reporting system
por: Makunts, Tigran, et al.
Publicado: (2023)

The Effects of Serotonergic Psychedelics on Neural Activity: A Meta-Analysis of Task-Based Functional Neuroimaging Studies
por: Shepherd, J. H., et al.
Publicado: (2023)

Sleep Quality Improvements After MDMA‐Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder
por: Ponte, Linnae, et al.
Publicado: (2021)

Effects of dextromethorphan on MDMA-induced serotonergic aberration in the brains of non-human primates using [(123)I]-ADAM/SPECT
por: Ma, Kuo-Hsing, et al.
Publicado: (2016)

Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
por: Galvão-Coelho, Nicole L., et al.
Publicado: (2021)

Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics
por: Abrams, Stephanie Karzon, et al.
Publicado: (2023)

Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice
por: Takaba, Rika, et al.
Publicado: (2023)

Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
por: Schlag, Anne K, et al.
Publicado: (2022)

Psychedelic Cognition—The Unreached Frontier of Psychedelic Science
por: Bălăeţ, Maria
Publicado: (2022)

Methaemoglobinemia Induced by MDMA?
por: Verhaert, L. L. W.
Publicado: (2011)

Extasis (MDMA) : un abordaje comprehensivo /
por: Bobes García, Julio
Publicado: (1998)

Extended difficulties following the use of psychedelic drugs: A mixed methods study
por: Evans, Jules, et al.
Publicado: (2023)

Oral S-ketamine effective after deep brain stimulation in severe treatment-resistant depression and extensive comorbidities
por: Veraart, Jolien K E, et al.
Publicado: (2021)

Preliminary Results on the Long-Term Effects of Dextromethorphan on MDMA-Mediated Serotonergic Deficiency and Volumetric Changes in Primates Based on 4-[(18)F]-ADAM PET/MRI
por: Yeh, Skye Hsin-Hsien, et al.
Publicado: (2022)

Psychedelic Psychiatry
por: Nutt, D.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_149qaqq2371upvjgna3do9f4qu